{"id":"W2980374528","doi":"10.1159/000503419","title":"Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer","year":2019,"lang":"en","type":"article","venue":"Case Reports in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lenvatinib; Medicine; Sorafenib; Regorafenib; Thyroid cancer; Follicular thyroid cancer; Internal medicine; Oncology; Vandetanib; Thyroid; Cancer; Papillary thyroid cancer; Hepatocellular carcinoma; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005124664,0.0001985479,0.0005991777,0.0003133607,0.00002192864,0.000006018544,0.00002621227,0.0001599745,0.0001895387],"category_scores_gemma":[0.0001838061,0.0001484046,0.00004793295,0.0003795445,0.00004623574,0.0000489996,0.00004930007,0.0002888117,0.00002039072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002238154,"about_ca_system_score_gemma":0.001070939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00109438,"about_ca_topic_score_gemma":0.005753943,"domain_scores_codex":[0.9981162,0.0001629314,0.0005632606,0.0005825467,0.0002056829,0.000369399],"domain_scores_gemma":[0.9986733,0.0002051494,0.0002413034,0.0005882182,0.00009772424,0.0001943357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01368327,0.001367181,0.194374,0.00004320948,0.00005713764,0.766453,0.002099033,0.0002935581,0.003337433,0.000007262129,0.001482258,0.01680271],"study_design_scores_gemma":[0.01574403,0.03427255,0.2680127,0.001063882,0.0001926276,0.3176514,0.00166845,0.00004018328,0.005089577,0.00002996448,0.3555775,0.0006571212],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901958,0.001695002,7.998036e-7,0.004177174,0.0003568306,0.001938863,0.000006328458,0.00003150701,0.001597701],"genre_scores_gemma":[0.9965014,0.0001399272,0.0003166412,0.001087931,0.00005455679,0.001323669,0.000008019785,0.00003111929,0.0005367172],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4488016,"threshold_uncertainty_score":0.6051763,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01321743340245038,"score_gpt":0.3176593273283082,"score_spread":0.3044418939258579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}